Form 8-K - Current report:
SEC Accession No. 0001193125-25-069706
Filing Date
2025-04-01
Accepted
2025-04-01 08:00:13
Documents
15
Period of Report
2025-04-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d888264d8k.htm   iXBRL 8-K 38221
2 EX-99.1 d888264dex991.htm EX-99.1 35989
6 GRAPHIC g888264dsp12.jpg GRAPHIC 11409
  Complete submission text file 0001193125-25-069706.txt   227552

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hura-20250401.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hura-20250401_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hura-20250401_pre.xml EX-101.PRE 11264
18 EXTRACTED XBRL INSTANCE DOCUMENT d888264d8k_htm.xml XML 3718
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 25796651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)